Naveen Pemmaraju: Awesome team to round with on Leukemia Inpatient wards this month
Naveen Pemmaraju recently posted on X:
“Awesome team to round with on Leukemia Inpatient wards this month. Major shout out to our amazing Leukemia Advanced Practice Providers (APPs) – the best in the world!
Left to right: Naveen Pemmaraju, Jennifer Reed, Grace Park, Rachel Koller, Sara Aparece, Tanea Montgomery.”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN, and AML.
He has been named MDACC’s, Department of Leukemia, Inaugural Director of the BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023